维普期刊资源整合服务平台（V6.5）

108篇 您的检索式：作者名="GUGLIELMELLI P"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Robotics for medical applications 显示文摘	Dario P Guglielmelli E Allotta B	1996	IEEE Robotics & Aut-omation Magazine1996，3，3：	2
2	Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia 显示文摘	Rotunno G Mannarelli C Guglielmelli P	2014	Blood2014，123，10：	1
3	Clinical corre- lates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal 显示文摘	Vannucchi AM Antonioli E Guglielmelli P	2008	Leukemia2008，22，7：	1
4	Robotics for Medical Applications 显示文摘	Dario P Guglielmelli E Allotta B C	1996	IEEE Robotics and Automation Magazine1996，3，3：	1
5	Hypermethylation of CXCR4 promoter in CD34^+ cells from patients with primary myelofibrosis 显示文摘	Bogani C Ponziani V Guglielmelli P	2008	Stem Cells2008，26，8：	1
6	Type 1 versus type 2 calreticulin mutations in essential thrombocythemia:a collaborative study of 1 027 patients 显示文摘	Tefferi A Wassie EA Guglielmelli P	2014	Am J Hematol2014，89，8：	1
7	Anaemia characterises patients with myelofibrosis harbouring Mpl mutation显示文摘	Guglielmelli P Pancrazzi A Bergamaschi G		0，，03：	1
8	CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients 显示文摘	Tefferi A Guglielmelli P Lasho TL	2014	Leukemia2014，28，7：	1
9	Safety and efficacy of everolimus, a roTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis显示文摘	Guglielmelli P Barosi G Rambaldi A	2011	Blood2011，118，8：	1
10	Impact of calreti- culin mutations on clinical and hematological phenotype and out- come in essential thrombocythemia显示文摘	Rotunno G Mannarelli C Guglielmelli P	2014	Blood2014，123，10：	1
11	Advances in understanding and management of myeloproliferative neoplasms显示文摘	Vannucchi AM Guglielmelli P Tefferi A		0，，：	1
12	The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera显示文摘	PIERI L BOGANI C GUGLIELMELLI P	2009	Haematologica2009，94，：	1
13	Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collabora- tive study of 1027 patients 显示文摘	Tefferi A Wassie EA Guglielmelli P	2014	Am J Ylematol2014，89，8：	1
14	Humanoids and personal robots:Design and experiments显示文摘	DARIO P GUGLIELMELLI E LASCHI C	2001	Journal of Robotic Systems2001，18，12：	1
15	Molecular pro- filing of CD34 cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical signif- icance of Wilms' tumor gene 1 (WT1) 显示文摘	GUGLIELMELLI P ZINI R BOGANI C	2007	Stem Cells2007，25，1：	1
16	Calreticulin muta- tion does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia 显示文摘	Finazzi G Carobbio A Guglielmelli P	2014	Blood2014，124，16：	1
17	Inconsistencies in the association between the JAK2 (V617F) mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 显示文摘	Vannucchi AM Guglielmelli P Antonioli E	2006	Br J Haematol2006，132，5：	1
18	Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis显示文摘	Bogani C Ponziani V Guglielmelli P	2008	Stem Cells2008，26，8：	1
19	Impact of calreti- culin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia显示文摘	Rotunno G Mannarelli C Guglielmelli P	2014	Blood2014，123，10：	1
20	CALR and ASXL1 mutations - based molecular prognostication in primary myelofibro- sis: an international study of 570 patients显示文摘	Tefferi A Guglielmelli P Lasho TL	2014	Leukemia2014，28，7：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示